Transcat, Inc.
NASDAQ:TRNSIndustrial - Distribution
+$2.00 today
- Market cap
- $937.19M
- Beta
- 0.70
- P/E (TTM)
- 150.2
- EPS (TTM)
- $0.62
Volume 0.14M
Average 0.16M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Transcat, Inc.
NASDAQ:TRNS
Intrinsic Alpha fair value
Locked
Current Price
$99.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -25.9% | +36.5% (6yr)1 analysts |
| Revenue | N/A | N/A | +12.9% | +6.6% (6yr)1 analysts |
| Net Income | N/A | N/A | -20.5% | +36.3% (6yr)1 analysts |
| EBIT | N/A | N/A | -6.5% | +23.6% (6yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +12.9% over three years. Forward estimates point to EPS at +36.5% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Mettler-Toledo International Inc. NYSE:MTD | $34.59B | $1,738.91 | Overvalued | 26.6 | +22.66% |
Bio-Techne Corporation NASDAQ:TECH | $11.44B | $72.80 | Overvalued | 78.3 | +25.31% |
Bio-Rad Laboratories, Inc. NYSE:BIO | $9.85B | $366.36 | Fairly Valued | 45.4 | +16.38% |
UFP Technologies, Inc. NASDAQ:UFPT | $2.36B | $305.06 | Undervalued | 26.8 | +36.10% |
TIC Solutions, Inc. NYSE:TIC | $2.32B | $10.62 | Overvalued | -12.7 | +6.26% |
NeoGenomics, Inc. NASDAQ:NEO | $2.07B | $16.02 | Not rated | -2.9 | +46.49% |
BioLife Solutions, Inc. NASDAQ:BLFS | $1.89B | $38.61 | Overvalued | -119.9 | +60.67% |
QuidelOrtho Corporation NASDAQ:QDEL | $736.90M | $10.74 | Overvalued | -0.7 | -53.62% |
Alpha Teknova, Inc. NASDAQ:TKNO | $516.43M | $8.21 | Not rated | -16.2 | +73.47% |
Standard BioTools Inc. NASDAQ:LAB | $279.27M | $0.71 | Not rated | -3.5 | -56.50% |
Continue the stock analysis
Jump to another research area for this company.